Business Context and Reporting Period
This Form 8-K Current Report was filed by ReWalk Robotics Ltd. (noted as Lifeward Ltd. in metadata) on October 27, 2016. The filing reports the entry into a material definitive agreement regarding a public offering of securities.
Key Financial Metrics and Transaction Details
The filing details a public offering of 3,250,000 Units at a price of $3.75 per Unit. Each Unit consists of one Ordinary Share and 0.75 of a Warrant to purchase one Ordinary Share.
- Gross Proceeds: Approximately $12.19 million (3,250,000 Units x $3.75).
- Underwriter: Oppenheimer & Co. Inc.
- Underwriting Commission: 7.0% on the first $10.0 million of gross proceeds; 5.0% on gross proceeds exceeding $10.0 million.
- Over-Allotment Option: The underwriter has a 30-day option to purchase up to 487,500 additional Units.
- Warrant Terms: Initial exercise price of $4.75 per share; exercisable from issuance until November 1, 2021.
Note: This filing does not provide historical revenue, profit, cash flow, margin, debt, or liquidity metrics for the company.
Material Changes
The primary material change is the execution of the Underwriting Agreement on October 27, 2016, initiating the capital raise described above. The filing does not provide comparative financial data to assess changes in operating performance versus prior periods.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference a press release regarding the pricing of the offering but does not contain specific forward-looking guidance on revenue or earnings within the text provided.
Risks and Contingencies:
- Dilution: The issuance of new shares and warrants will dilute existing shareholders.
- Warrant Adjustments: The exercise price and number of shares issuable upon exercise are subject to adjustment for corporate events (e.g., stock splits, dividends).
- Board Discretion: The Board of Directors retains the right to reduce the warrant exercise price at any time.
- Change of Control: In the event of a fundamental transaction or change of control, warrant holders may be entitled to cash repurchase based on the Black-Scholes model or receive alternate consideration.
Investor Verification Checklist
- Verify the final closing date and total gross proceeds raised, including any exercise of the over-allotment option.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) and Form of Warrant (Exhibit 4.1) for specific covenants and adjustment formulas.
- Confirm the use of proceeds as detailed in the accompanying prospectus supplement (referenced but not included in this text).
- Assess the impact of the 7.0%/5.0% underwriting discount on net capital raised.
- Monitor the company's cash position post-offering to evaluate runway for operations.